Crosspoint Capital Strategies’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AXGN
EWM
OM
ACH
Crosspoint Capital Strategies's AXGN Position: Q1 2018 in Review
Crosspoint Capital Strategies sold out of Axogen (AXGN) in Q1 2018, closing a stake of 591 shares — an estimated $167K sold.
Crosspoint Capital Strategies first reported a position in AXGN in Q3 2017 and held it in 2 quarters. The position peaked at $167K in Q4 2017. 147 funds tracked by Wall St. Rank hold AXGN as of Q1 2018.
- Crosspoint Capital Strategies reported no remaining Axogen position as of Q1 2018 after selling out during the quarter.
- Crosspoint Capital Strategies sold 591 Axogen shares in Q1 2018, an estimated $167K.
- Crosspoint Capital Strategies first reported a position in Axogen in Q3 2017 and held it in 2 quarters.
- Crosspoint Capital Strategies's Axogen position peaked at $167K in Q4 2017.
- 147 funds tracked by Wall St. Rank held Axogen as of Q1 2018.
Based on Crosspoint Capital Strategies's 13F filing for Q1 2018, filed 14 May 2018.